Search

Pharmaceuticals, Free Full-Text

$ 22.00 · 4.8 (154) · In stock

Despite extensive knowledge of the mechanisms responsible for childbirth, the course of labor induction is often unpredictable. Therefore, labor induction protocols using prostaglandin analogs have been developed and tested to assess their effectiveness in labor induction unequivocally. A total of 402 women were collected into two groups—receiving vaginal Misoprostol or vaginal Dinoprostone for induction of labor (IOL). Then, the patients were compared in groups depending on the agent they received and their gestational age. Most patients delivered within 48 h, and most of these patients had vaginal parturition. Patients who received the Dinoprostone vaginal insert required statistically significantly more oxytocin administration than patients who received the Misoprostol vaginal insert. Patients who received the Misoprostol vaginal insert used anesthesia during labor statistically more often. Patients who received Misoprostol vaginal inserts had a statistically significantly shorter time to delivery than those with Dinoprostone vaginal inserts. The prevalence of hyperstimulation was similar in all groups and remained low. Vaginal Misoprostol-based IOL is characterized by a shortened time to delivery irrespective of the parturition type, and a lower need for oxytocin augmentation, but also by an increased demand for intrapartum analgesia administration. A vaginal Dinoprostone-based IOL protocol might be considered a more harmonious and desirable option in modern perinatal care.

Pharmaceuticals, Free Full-Text

Pharmaceuticals Free Full-Text Preclinical Efficacy And, 54% OFF

Physicians EZ Use B-12

Pharmaceuticals, Free Full-Text

Pharmaceuticals, Free Full-Text

Pharmaceuticals, Free Full-Text, igor's costela

Synergistic removal of pharmaceuticals and antibiotic resistance

Pharmaceuticals, Free Full-Text

Pharmaceuticals, Free Full-Text

Pharmaceutical Ideas: Over 12,516 Royalty-Free Licensable Stock

Medique Dover 2125323 Sudanyl PE Decongestant Tablets

Generative AI Use Cases in the Pharmaceutical Industry: A

ACCELERATE Platform Innovation for Children with Cancer, accelerate